Literature DB >> 10633034

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism.

K Biggadike1, R M Angell, C M Burgess, R M Farrell, A P Hancock, A J Harker, W R Irving, C Ioannou, P A Procopiou, R E Shaw, Y E Solanke, O M Singh, M A Snowden, R J Stubbs, S Walton, H E Weston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10633034     DOI： 10.1021/jm990436t

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  17 in total

1.  Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.

Authors:  Amir Aharoni; Leonid Gaidukov; Shai Yagur; Lilly Toker; Israel Silman; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

Review 2.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

3.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 4.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 5.  Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria.

Authors:  Jordi Camps; Isabel Pujol; Frederic Ballester; Jorge Joven; Josep M Simó
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

6.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

7.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

Review 8.  p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.

Authors:  Ramkumar Menon; John Papaconstantinou
Journal:  Expert Opin Ther Targets       Date:  2016-08-04       Impact factor: 6.902

Review 9.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

Review 10.  Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.

Authors:  M Omar F Khan; Henry J Lee
Journal:  Chem Rev       Date:  2008-12       Impact factor: 60.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.